KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Return on Sales (2016 - 2026)

Boston Scientific's Return on Sales history spans 18 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q1 2026 for Boston Scientific, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for BSX hit a ceiling of 0.0% in Q1 2026 and a floor of 0.0% in Q1 2022.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
  • The widest YoY moves for Return on Sales: up 0bps in 2022, down 0bps in 2022.
  • Tracing BSX's Return on Sales over 5 years: stood at 0.0% in 2022, then surged by 211bps to 0.0% in 2023, then dropped by -9bps to 0.0% in 2024, then grew by 3bps to 0.0% in 2025, then skyrocketed by 103bps to 0.0% in 2026.
  • Business Quant data shows Return on Sales for BSX at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.